Microbiome & Mitochondrial Intervention Research
Research into gut-brain axis modulation, microbiome composition optimization, mitochondrial biogenesis, and metabolic rescue strategies. No FMT — focused on targeted prebiotics, postbiotics, and mitochondrial activators.
Key Mechanisms
- Short-chain fatty acid (SCFA) production and immune regulation
- Gut barrier integrity and molecular mimicry prevention
- PGC-1α–driven mitochondrial biogenesis
- NAD+ salvage pathway restoration
- Akkermansia muciniphila abundance modulation
Notable Compounds
- Butyrate / tributyrin
- Akkermansia muciniphila
- Urolithin A (mitophagy)
- NMN / NR (NAD+ precursors)
- PQQ (pyrroloquinoline quinone)
- Sulforaphane (Nrf2 activation)
Disease-Specific Research
- Microbiome & Mitochondrial Intervention Research for ALS (Amyotrophic Lateral Sclerosis)
- Microbiome & Mitochondrial Intervention Research for Stage IV Cancer
- Microbiome & Mitochondrial Intervention Research for Alzheimer's Disease
- Microbiome & Mitochondrial Intervention Research for Parkinson's Disease
- Microbiome & Mitochondrial Intervention Research for Autoimmune Diseases